EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. GOOGL

Go back to EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress

EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss of $0.62, Revenues Beat

September 12, 2018 6:09 AM EDT

EyePoint Pharmaceuticals (NASDAQ: EYPT) reported Q4 EPS of ($0.62), versus ($0.11) reported last year. Revenue for the quarter came in at $715 thousand versus the consensus estimate of $690 thousand.

During EyePoints fiscal fourth quarter, we made significant clinical, corporate and financial achievements that have contributed to the Companys rapid advancement towards commercialization, said Nancy... More